Clinical pharmacogenomics: Applications in pharmaceutical R&D

Drug Discovery Today

Volumn 6, Issue 4, 2001, Pages 180-185

  Norton, Ronald M ^a  

^a PPGx Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; SEROTONIN RECEPTOR;

CLINICAL RESEARCH; DNA LIBRARY; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG INDUSTRY; DRUG METABOLISM; DRUG QUALITY; DRUG RESPONSE; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; LAW; PHARMACOECONOMICS; PHARMACOGENOMICS; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; RISK BENEFIT ANALYSIS; SHORT SURVEY;

EID: 0035254858     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01648-2     Document Type: Review

References (24)

1. Moderne Problem der Humangenetik
2. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies
3. The incidence of alcaptonuria: a study in chemical individuality
4. Enzymatic inactivation of isonicotinic acid hydrazide in humans and animals
5. Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D
6. Drug discovery: a historical perspective
7. The use of single-nucleotide polymorphism maps in pharmacogenomics
8. Pitfalls in the drug approval process: dose effect, experimental design and risk-benefit issues
9. Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a Phase III clinical trial
10. Pharmacogenomics: translating functional genomics into rational therapeutics
11. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortryptoline and other tricyclic antidepressants
12. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans
13. Interphenotype differences in disposition and effect on gastrin levels of omeprazole - suitability of omeprazole as a probe for CYP2C19
14. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
15. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk
16. Association of CYP3A4 genotype with treatment-related leukemia
17. Population distribution and effects on drug metabolism of a genetic variant in the 5′ promoter region of CYP3A4
18. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5(-promoter region polymorphism
19. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
20. Association between genetic polymorphisms of the (2-adrenoceptor and response to albuterol in children with and without a history of wheezing
21. 2A receptors and clozapine response